Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Rankning i aktier #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Aktiekurs
$29.06
Senast synkroniserad: 2023-02-23
Marknadsvärde
$682.73M
Förändring (1 dag)
-0.48%
Förändring (1 år)
0.00%
Land
US
Handel CinCor Pharma, Inc. (CINC)

Kategori

Historik för aktiesplit för CinCor Pharma, Inc. (CINC)
Aktien CinCor Pharma, Inc. (symbol: CINC) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 30, 2026.
En CINC-aktie köpt före Aug 30, 2026 motsvarar nu 0 CINC-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH